Assignee
PROVECTUS PHARMATECH INC
US17 patents
Top patents by PatentIndex Score
US7648695B2Jan 19, 2010
Medicaments for chemotherapeutic treatment of disease
PROVECTUS PHARMATECH INC24 citations92
US7390668B2Jun 24, 2008
Intracorporeal medicaments for photodynamic treatment of disease
PROVECTUS PHARMATECH INC22 citations92
US7402299B2Jul 22, 2008
Intracorporeal medicaments for photodynamic treatment of disease
PROVECTUS PHARMATECH INC12 citations83
US10471144B2Nov 12, 2019
Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer
PROVECTUS PHARMATECH INC5 citations82
US11071781B2Jul 27, 2021
Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer
PROVECTUS PHARMATECH INC1 citations73
US7384623B1Jun 10, 2008
High energy phototherapeutic agents
PROVECTUS PHARMATECH INC8 citations72
US11058664B2Jul 13, 2021
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC1 citations69
US7427389B2Sep 23, 2008
Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes
PROVECTUS PHARMATECH INC2 citations63
US7338652B2Mar 4, 2008
Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agents
PROVECTUS PHARMATECH INC2 citations63
US7863047B2Jan 4, 2011
Intracorporeal medicaments for photodynamic treatment of disease
PROVECTUS PHARMATECH INC1 citations62
US12377068B2Aug 5, 2025
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC0 citations59
US11974980B2May 7, 2024
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
PROVECTUS PHARMATECH INC0 citations59
US12133840B2Nov 5, 2024
Halogenated xanthene composition and method for treating hematologic cancers
PROVECTUS PHARMATECH INC0 citations58
US11419844B2Aug 23, 2022
Halogenated xanthene composition and method for treating hematologic cancers
PROVECTUS PHARMATECH INC0 citations58
US12064507B2Aug 20, 2024
Composition and method for oral treatment of leukemia
PROVECTUS PHARMATECH INC0 citations55
US11975106B2May 7, 2024
Uses of halogenated xanthenes in oncology and virology
PROVECTUS PHARMATECH INC0 citations55
US11938182B2Mar 26, 2024
Halogenated xanthenes as vaccine adjuvants
PROVECTUS PHARMATECH INC0 citations53